|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Nanorover for Mars 显示文摘 | BRIAN W ANNETTE N RICK W A | 1997 | Space Technology1997，17，3： | 1 |
| 2 | The evolving role of haematopoietic cell transplantation in radiation injury:potentials and limitations显示文摘 | Dainiak N Ricks RC | | 0，，： | 1 |
| 3 | Toward the Development of Metal-based Synthetic Nucleases and Pep-tidases:A Rationale and Progress Report in App lying the Principles of Coordination Chemistry显示文摘 | JUDITH N B | 1998 | Coordination Chemistry Reviews1998，173，： | 1 |
| 4 | Effect of calcium and water injection on structure-function relationships of cheese显示文摘 | Pastorino A J Ricks N P Hansen C L | 2003 | J Dairy Sci2003，86，： | 1 |
| 5 | Endometrial Cancer显示文摘 | Frederic A Philippe M Pat rick N | 2005 | Lancet2005，366，9484： | 1 |
| 6 | Lack of a functional p21WAF1/CIP1 gene accelerates caspase-indepentdent apoptosis induced by cisplatin in renal cells 显示文摘 | Grazyna N Peter M P Rick G S | 2003 | Am J Physiol Renal Physiol2003，285，3： | 1 |
| 7 | Toward the Development of Metal - based Synthetic Nucleases and Peptidases : A Rationale and Progress Report in Applying the Principles of Coordination Chemistry 显示文摘 | RICK L HEGG JUDITH N BURSTYN | 1998 | Coordination Chemistry Reviews1998，173，： | 1 |
| 8 | Chlorpyrifos:Pharmacokinetics in human volunteers following single oral and dermal doses显示文摘 | Nolan R J Rick D L Freshour N L | 1984 | Toxicol Appi Pharmacol1984，73，： | 1 |
| 9 | PBPC mobilization with paclitaxel, ifosfamide, and G-CSF with or without amifostine: results of a prospective randomized trial 显示文摘 | Rick O Schwella N Beyer J | 2001 | Transfusion2001，41，2： | 1 |
| 10 | Bm -CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi , inhibits class II MHC-restricted antigen processing显示文摘 | Bénédicte Manoury William F. Gregory Rick M. Maizels Colin Watts | 2001 | Current Biology2001，，6： | 1 |
| 11 | Revisiting mor- tality predictability of serum album in the dialysis populationattribut- able fraction 显示文摘 | Kalantar-Zadeh K Kilpat rick RD Kuw ae N | 2005 | NephrolDial Transplant2005，20，9： | 1 |
| 12 | Turn or vascular pemeability factor stimulates endothelial cell grow th and angiogenesis 显示文摘 | Daniel TC Deborah MH Rick N | 1989 | J C lin Invest1989，11，84： | 1 |
| 13 | Database of mutations in the p53 and APC tumor suppressor genes designed to facilitate molecular epidemiological analyses 显示文摘 | De Vries E M Ricke D O De Vries T N | 1996 | Hum Mutat1996，7，3： | 1 |
| 14 | Operational performance of the TIMED doppler interferometer (TIDI) 显示文摘 | WILBERT R S RICK J N TIMOTHY L K | 2003 | Proceedings of SPIE2003，5175，： | 1 |
| 15 | Homocysteine induced endothelial cell toxicity and its protection 显示文摘 | BLUNDELL G FRED E D RICK N R | 1994 | Biothem Scc Transac1994，22，3： | 1 |
| 16 | Nuclear receptor/microRNA circuitry links muscle fiber type to energy metabolism显示文摘 | Gan Zhenji Rumsey John Hazen Bethany C Lai Ling Leone Teresa C Vega Rick B Xie Hui Conley Kevin E Auwerx Johan Smith Steven R Olson Eric N Kralli Anastasia Kelly Daniel P | 2013 | Journal of Clinical Investigation2013，，6： | 1 |
| 17 | Age-related macular degeneration treatment in the era of molecular medicine显示文摘Age-related macular degeneration(AMD) is the leading cause of irreversible blindness in the developed world. The quality of life of both patients and families is impacted by this prevalent disease. Previously, macular degeneration had no known effective treatment. Today, vitamins for non-exudative AMD and intravitreal injection of medications for its exudative form are primary forms of current treatment. Modern advances in molecular science give rise to new possibilities of disease management. In the year 2003 the sequencing of the entire human genome was completed. Since that time, genes such as complement factor H, high-temperature requirement factor A1, and age-relateed maculopathy susceptibility 2 have been discovered and associated with a higher risk of AMD. A patient's genetic make-up may dictate the effectiveness of current or future therapeutic options. In addition, utilizing genetic data and incorporating it into new treatments(such as viral vectors) may lead to longer-lasting(or permanent) VEGF blockade and specific targeting of complement related genes. There have also been considerable advances in stem cell directed treatment of AMD. Retinal pigment epithelial(RPE) cells can be derived from human embryonic stem cells, induced pluripotent stem cells, or adult human RPE stem cells. Utilizing animal models of RPE and retinal degeneration, stem cell-derived RPE cells have been successfully implanted into the subretinal space. They have been injected as a cell mass or as a pre-prepared monolayer on a thin membrane. Visual recovery has been demonstrated in a retinal dystrophic rat model. Preliminary data on 2 human subjects also demonstrates possible early visual benefit from transplantation of stem cell-derived RPE. As more data is published, and as differentiation and implantation techniques are optimized, the stabilization and possible improvement of vision in individuals with non-exudative macular becomes a real possibility. We conclude that the technologic advances that continue to unfold in both genetic and stem cell research offer optimism in the future treatment of AMD. | Rick N Nordgren Ahmed M Elkeeb Bernard F Godley | 2014 | World Journal of Ophthalmology2014，4，4： | 1 |
| 18 | Tum or vascular pemeability factor stimulates endothelial cell grow th and angiogenesis 显示文摘 | Daniel TC Deboran MH Rick N | 1989 | J Clin Invest1989，11，84： | 1 |
| 19 | Analysis of left ventricular diastolic function显示文摘 | Kazuhiro Y Margart M R Rick A N | 1996 | Heart1996，75，2： | 1 |
| 20 | The genome of Clostridium kluyveri, a strict anaerobe with unique metabolic features显示文摘 | Seedorf H N Ricke W F Veith B | 2008 | Pro: Natl Acad S:i2008，105，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员